Neulastim

Neulastim is a hematopoietic stimulant medicine with active substance Pegfilgrastima.

This oral medication is indicated for the treatment of neutropenia related to chemotherapy.

Indications of Neulastim (For what it serves)

Neutropenia.

Side effects of Neulastim

Abdominal pain; lack of appetite; constipation; diarrhea; indigestion; inflammation of mucosa; nausea; inflammation in the mouth; changes in taste; vomiting; fever; joint pain; pain in the bones; weakness; muscle pain; loss of hair; dizziness; fatigue; Headache; insomnia.

Contraindications of Neulastim

Pregnancy risk C; women in the lactation phase; children; 14 days or 24 hours after administration of cytotoxic drugs; Hipersensibility to any of the formula's components.

How to use Neulastim (Dosage)

Injectable Use

Adults

• 6 mg, subcutaneously, once every cycle of chemotherapy.